Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Net Debt
Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.
Net Debt history
Currency unavailable · from the balance sheet
No Net Debt data reported for this period type.
Net Debt vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.02B USD | +29.6% | +19.3% | 52.8% | |
| Mar 2026 | -$49.57M USD | +32.4% | — | 28.6% | |
| Mar 2026 | -$70.77M USD | -73.2% | — | 52.4% | |
| Mar 2026 | -$265.17M USD | — | — | 90.7% | |
| Jun 2026 | -$424.07M USD | +24.7% | — | 60.2% | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | +27.2% | +19.3% | 52.8% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.